MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Reproductive factors and risk of Parkinson’s disease in women: preliminary results from the French prospective cohort E3N.

    G. Pesce, F. Artaud, E. Roze, I. Degaey, A. Fournier, MC. Boutron-Ruault, A. Elbaz, M. Canonico (Villejuif, France)

    Objective: Objective: To evaluate whether reproductive factors and use of exogenous hormones are associated with the risk of Parkinson’s disease (PD) in women. Background: Background:…
  • MDS Virtual Congress 2021

    Intensive rehabilitation program for patients with functional motor disorders: 3-years’ experience.

    B. Martín Rojo, L. Martínez López, P. Rada Romero, C. Vicente Torcal, M. García Ibañez, B. Borda Nuin, M. Sanz Amador, C. Delgado Suarez, M. Kurtis Urra, I. Pareés Moreno (Madrid, Spain)

    Objective: To describe the clinical characteristics and the outcomes of a cohort of patients with functional movement disorders (FMD) who attended the FMD clinic of…
  • MDS Virtual Congress 2021

    Neural oscillations modulation during working memory in premanifest and early Huntington’s disease

    G. Bonassi, M. Semprini, P. Mandich, L. Trevisan, R. Marchese, G. Lagravinese, F. Barban, E. Pelosin, M. Chiappalone, D. Mantini, L. Avanzino (Genova, Italy)

    Objective: To test whether high-density electroencephalography (hdEEG) coupled to source localization allows for the identification of neuronal oscillations in specific frequency bands in patients with…
  • MDS Virtual Congress 2021

    Atypical gait in a patient with Huntington’s Disease (HD): Functional movement disorders in the spectrum of motor phenotypes in HD

    H. Leal Bailey, K. Block, E. Furr-Stimming, S. Chandra (Houston, USA)

    Objective: We describe a case of Huntington’s disease (HD) associated chorea and concurrent functional movement disorder (FMD). Background: HD is a neurodegenerative disorder characterized by…
  • MDS Virtual Congress 2021

    Validation of biomarkers in Huntington’s disease to support the development of disease-modifying therapies: a systematic review and critical appraisal scheme

    H. Tang, T. van Eimeren, C. Sampaio, T. Mestre (Ottawa, Canada)

    Objective: To review studies for disease progression biomarkers published in HD and evaluate their methodological quality in a standardized manner. Background: Huntington disease (HD) is a fatal autosomal dominant neurodegenerative condition that starts to manifest clinically around the 4th decade of life. There are promising novel genetic-based therapies under development intended to modify the disease trajectory. Valid…
  • MDS Virtual Congress 2021

    Neural correlates of executed compared to imagined writing and drawing movements. An fMRI study

    C. Gless, A. Baumann, I. Tödt, A. Knutzen, O. Granert, S. Wolff, JS. Becktepe, K. Witt, KE. Zeuner (Kiel, Germany)

    Objective: In this study we used functional magnetic resonance imaging (fMRI) to investigate whether motor imagery (MI) of handwriting and circle drawing activates a similar…
  • MDS Virtual Congress 2021

    Neutralizing Antibody Conversion With OnabotulinumtoxinA From Global Studies Across Multiple Indications With A Focus On Movement Disorders: A Meta-Analysis

    J. Jankovic, J. Carruthers, M. Naumann, T. Boodhoo, S. Gupta, M. Attar, R. Singh, I. Yushmanova, J. Soliman, MF. Brin, J. Shen (Houston, USA)

    Objective: A meta-analysis of clinical trial data across 10 indications for onabotulinumtoxinA was performed to assess incidence of neutralizing antibody (nAb) formation with a focus…
  • MDS Virtual Congress 2021

    Botulinum toxin injections for sialorrhea in Parkinson´s disease and parkinsonism: 5 years follow up

    C. Borrue, C. Jimeno (Madrid, Spain)

    Objective: Investigate the safety and efficacy of botulinum toxin type A in Parkinson´s disease and parkinsonism patients affected by sialorrhea Background: Sialorrhea is excessive salivation…
  • MDS Virtual Congress 2021

    Experiences of home-based dance participation in people with Parkinson’s

    J. Bek, M. Groves, D. Leventhal, E. Poliakoff (Manchester, United Kingdom)

    Objective: To investigate experiences of people with PD in using digital resources for home-based dance participation during the COVID-19 pandemic. Background: Dance is associated with…
  • MDS Virtual Congress 2021

    Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium

    M. Muller, D. Dexter, J. Cosman, C. Zadikoff, S. Ali, N. Barwick, B. Bloem, B. Boroojerdi, J. Burton, C. Carroll, J. Cedarbaum, T. Dam, P. Dawkins, D. Grosset, N. Hanan, D. Hill, M. Hu, D. Jennings, S. Jones, K. Kieburtz, R. Lawson, K. Lee, K. Marek, H. Matthews, N. Mehrotra, J. Molinuevo, P. Muglia, A. Naito, G. Pagano, S. Sardi, M. Schwarzschild, A. Simen, T. Simuni, G. Stebbins, C. Venuto, C. Williams-Gray, D. Stephenson (Tucson, USA)

    Objective: An update on the accomplishments of the Critical Path for Parkinson’s (CPP) Consortium. Background: The pharmaceutical pipeline for Parkinson’s disease (PD) is rapidly expanding. Data sharing will facilitate decision making during the development…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 132
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley